Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since. 

Share:
More In Science
Need2Know: February 10, 2023
The death toll in the Turkey Syria earthquake has passed 21,000, Minnesota Rep. Angie Craig was attacked, and shots to stop bird flu. Here is everything you Need2Know for Friday, February 10, 2023.
Load More